-
Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Screening for Colorectal Cancer: Role of Perspective
Sep 9, 2025, 16:22 PM -
Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Sep 9, 2025, 16:22 PM -
Persistence With Osteoporosis Medication Treatments Among Chinese Patients With Osteoporosis: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Impact of Resmetirom on Liver Transplant Demand and Outcomes in US Patients With MASH
Sep 9, 2025, 16:22 PM -
What Has Worked Well in Fabry Disease? An HTA Landscape Assessment Study
Sep 9, 2025, 16:22 PM -
Value of in Vitro Diagnostic IVD Tests in Health Society and Economy in Portugal
Sep 9, 2025, 16:22 PM -
Economic Impact of Poison Control Center Interventions on Hospitalization Costs in Algeria: A Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Second-Line Antidiabetic Medications on the Risk of Major Adverse Cardiovascular Events: A Real-World Study in China
Sep 9, 2025, 16:22 PM -
How Can Intravitreal Aflibercept 8 mg Impact Treatment Burden and Costs in European Patients With Diabetic Macular Edema? From Clinical Trials to Clinical Practice
Sep 9, 2025, 16:22 PM -
Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Assessing the Burden of 22q11.2 Deletion Syndrome (22q11DS) at Family Level
Sep 9, 2025, 16:22 PM -
Optimal Utilization of Robotic-Assisted Surgery in the NHS: A System-Level Economic Evaluation Model
Sep 9, 2025, 16:22 PM -
Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes
Sep 9, 2025, 16:22 PM -
Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region
Sep 9, 2025, 16:22 PM -
Evaluating Patient Preferences for Clinical Trial Endpoints in Early Stage Cancer: A Discrete Choice Experiment in Canada
Sep 9, 2025, 16:22 PM -
From Policy to Practice: Are Larger Member States Leading the Way for Joint Clinical Assessments?
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Screening Program for Chronic Kidney Disease in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Evolution of Acceptance of Evidence and PMA Outcomes by HTA Authorities for ATMPs in the EU4 and the UK 2017-2025
Sep 9, 2025, 16:22 PM